baber/WOPTO huggingface dataset:
Patent DK-0384553-T3 (DK)
Inventor: SCHMIDT HELGA
IPC: A23C19/16
Filed: 1990-02-14
Granted: 1993-08-23
Abstract: In the process, in addition to the conventional acidifying organisms, lactobacilli, optionally in combination with other microorganisms, are added to the vat milk, and cheese ripening is carried out in special films. In this manner a cheese is obtained corresponding in flavour, consistency and appearance to Tilsit cheese traditionally prepared by surface treatment, but which has a less strong odour than traditional Tilsit.
Patent DK-0382520-T3 (DK)
Inventor: SUZUKI KANEYUKI
IPC: E03D11/11
Filed: 1990-02-08
Granted: 1994-04-11
Abstract: A flush toilet of the present invention has a toilet stool (10) and an incinerating pot (14), interconnected by a vertical drain pipe (16). A shutter (18a) in the pipe (16) opens the pipe during evacuation or urination and closes after completing evacuation or urination. Raw sewage is introduced to the incinerating pot, and flush water is led to another place (34) so that the raw sewage can be efficiently incinerated. The flush water can be reused after filtration.
Patent DK-0388372-T3 (DK)
Inventor: PALUMBO GIANFRANCO
IPC: A61F13/49
Filed: 1990-03-13
Granted: 1994-02-14
Abstract: An absorbent element for use in disposable absorbent articles e.g. babies' diapers, has a discontinuous layer of hydrogelling absorbent particles disposed on its upper surface. Along the side regions of the element, either the whole sides or the central sections only, hydrogelling absorbent material is distributed at a greater concentration on the surface or within the element.
Patent DK-0452392-T3 (DK)
Inventor: RONGVED PAL
IPC: A61K47/48
Filed: 1990-01-15
Granted: 1995-07-03
Abstract: Heterocyclic chelating agents and salts thereof of formula I:     <IMAGE>  (I)  wherein X represents a bond, O or S, or a group CHR1 or NR3, each R1 represents H, a group OR3 or NR3R3, or an alkyl or alkoxyalkyl group optionally substituted by a hydroxyl group or by a group NR3R3 or CON3R3; each R2 represents H, or an alkyl or alkoxy group optionally substituted by a hydroxyl or aloxy group; each R3 represents H, an optionally hydroxylated alkyl group or a group CH2Y; Y represents a group COZ, CON(OH)R4, POZ2 or SO2Z; Z represents a group OR4, NR4R4 or    <IMAGE>   where each R11 is H, a hydroxyl group or an optionally hydroxylated alkyl group, s is 0, 1 or 2, and W is CHR11, NR11 or an oxygen atom; and each R4 represents H, or an optionally mono- or poly-hydroxylated alkyl, alkoxyalkyl or polyalkoxyalkyl group; with the provisos that where s is O then W is CHR11 and that where X represents a bond or CHR1, at least one group R1 or R2 represents other than H or an unsubstituted alkyl group. A process for preparing these agents and methods of heavy metal detoxification using these agents are alo described.
Patent DK-0486190-T3 (DK)
Inventor: MCDERMOTT THOMAS C
IPC: B01D63/10
Filed: 1991-11-04
Granted: 1996-05-20
Abstract: The subject of the present invention is an improved leaf packet useful in forming a spiral filtration module, and an improved module which results from utilization of the leaf packet and a method of preparing the leaf packet. The membrane sheet (10) utilized in forming a spiral filtration module is fused and densified in the area of its fold to increase the sheet density in this area and thus provide protection against mechanical failure. The densification includes the application of heat and pressure to the membrane surface (12) of the sheet so as to densify the membrane surface and seal it against the penetration of feed stream liquid while also densifying the membrane, the backing and an optional reinforcing strip (18).
Patent DK-0508993-T3 (DK)
Inventor: SAINT-REMY JEAN-MARIE
IPC: A61P3/08
Filed: 1990-12-31
Granted: 1994-05-09
Abstract: A pharmaceutical composition suitable for administration to human beings in the prevention or treatment of immunologic disorders includes: an immune complex of an antigen and a purified antibody specific thereto, the antigen being selected from a group consisting of antigens that cause pathogenic immunologic reactions in autoimmune disease and graft rejections, and the antigen and antibody being present in a ratio whereby the antibody blocks essentially all binding sites of the antigen; and a pharmacologically acceptable carrier or diluent. The invention also provides a method of administering the composition for treatment of autoimmune disease and treatment or prevention of graft rejections.
Patent DK-0514379-T3 (DK)
Inventor: SPINDLER JOERG
IPC: G01N35/10
Filed: 1990-12-27
Granted: 1995-02-13
Abstract: The multi-channel pipette described has a very large number, in particular ninety-six, parallel pump cylinders with fitting plungers (20). The pump cylinders are designed as apertures (18) in a cylinder block (14). The plungers (20) are mounted in an array corresponding to the disposition of the apertures (18), in particular an 8x12 array, preferably with a degree of play about the vertical, on a plate (16) which can be raised and lowered along guide-bars parallel to the longitudinal axes of the cylinders.
Patent DK-0539423-T3 (DK)
Inventor: JESCHKE RAINER
IPC: A61K8/00
Filed: 1991-07-09
Granted: 1995-05-29
Abstract: A hair dye is composed of a fluid, aqueous oxidizing dyeing composition (A) and of a fluid, aqueous oxidizing composition (B) that are mixed immediately before being applied to the hair, with a weight ratio between A and B comprised between 1:2 and 2:1, in order to form a gel-like dyeing product. The oxidizing dyeing composition contains as carrier 0,5 to 5 % in weight of a liquid fat acid, 1 to 5 % by weight of a C2?-C6?-polyol, 1 to 10 % by weight of an addition product of 1 to 5 moles of ethylene oxide to a C12?-C22?-fat alcohol and/or 1 to 6 % by weight of an addition product of 1 to 4 moles of ethylene oxide to a linear fat alkylamine having 12 to 22 C atoms, and if necessary 0 to 10 % in weight of a compound having the formula (I): R?1-(OC2?H4?)x?-A-(C2?H4?O)y?-R?2. The oxidizing composition (B) preferably contains 3 to 10 % in weight of hydrogen peroxide, 0,1 to 5 % by weight of a water-soluble, synthetic tenside and 1 to 5 % by weight of a dispersed acrylic and/or methacrylic acid polymer or copolymer.
Patent DK-0546833-T3 (DK)
Inventor: ORTEGA ANTONIO DAZA
IPC: C12N1/21
Filed: 1992-12-10
Granted: 1997-09-15
Abstract: There is disclosed a new calcium-regulated promoter to be used for increasing production of extracellular enzymes, or heterologous polypeptides, a recombinant vector that includes the DNA sequence of the promoter operatively linked to a DNA encoding said enzyme or polypeptide and a host organism transformed with the recombinant vector that includes the promoter operatively linked to the DNA encoding said enzyme or polypeptide. The present invention further relates to Streptomyces expression systems and methods for expressing foreign DNA sequences in Streptomyces and for secreting to the surrounding medium polypeptides and proteins coded for by those foreign DNA sequences.
Patent DK-0590386-T3 (DK)
Inventor: KRIEGER WILFRIED DIPL-ING
IPC: A61F2/74
Filed: 1993-09-10
Granted: 1997-12-22
Abstract: The invention relates to a joint or pivoting connection for orthopaedic prostheses and ortheses, which comprises a joint upper part (1), a joint lower part (2) and, where appropriate, interposed guides (9, 10) (in the following summarized under the term "joint members") and a control element (4) which engages operatively on both sides of a joint member (1; 1, 2) (in the following "articulation joint member") via a respective articulation point (7, 8) spaced apart from an articulation axle (3; 20, 21; 25, 26). To improve this the invention proposes that at least one of said articulation points (7, 8) be arranged so that its position can be varied relative to its articulation joint member (1; 1,2) and be kinematically connected to at least one other joint member (2; 9, 10; 9) via a mechanical forced coupling (11, 12, 13, 14; 15, 16, 17; 18, 24; 30; 31). <IMAGE>
Patent DK-0583807-T3 (DK)
Inventor: PO RICCARDO
IPC: C08G63/91
Filed: 1993-07-01
Granted: 1997-04-14
Abstract: Polyethyleneterephthalate (PET) originating from the sorted collection of solid urban refuse can be regraded and recycled as such or mixed with virgin PET if treated at high temperature with an oxazoline of general formula: <CHEM>   <IMAGE>
Patent DK-0677125-T3 (DK)
Inventor: LYRMALM EBBE
IPC: D21H17/28
Filed: 1993-06-17
Granted: 1996-06-10
Abstract: PCT No. PCT/SE93/00541 Sec. 371 Date Jan. 6, 1995 Sec. 102(e) Date Jan. 6, 1995 PCT Filed Jun. 17, 1993 PCT Pub. No. WO94/01619 PCT Pub. Date Jan. 20, 1994The present invention provides a paper sizing composition which comprises a sizing agent selected from cyclic dicarboxylic acid anhydride or alkyl ketene dimer, a stabilizing and/or dispersing agent which is an amphoteric polymer and a polyaluminum compound.
Patent DK-0660840-T3 (DK)
Inventor: DE LOMBAERT STEPHANE
IPC: A61P9/00
Filed: 1993-08-24
Granted: 1997-07-14
Abstract: The present invention relates to the N-phosphonomethyl substituted tetrazole derivatives of formula (I) and tautomers thereof wherein R0 represents (i) a group of formula (Ia) or (ii) a group of formula -X-COR3 (Ib); R and R' represent independently hydrogen, carbocyclic aryl, 6-tetrahydronaphthyl, 5-indanyl, (alpha)-(trichloromethyl, carboxyl, esterified carboxyl or amidated carboxyl) substituted-(lower alkyl or aryl-lower alkyl), acyloxymethyl optionally monosubstituted on methyl carbon by lower alkyl, by C5-C7-cycloalkyl, by aryl or by aryl-lower alkyl; R1 represents phenyl, or phenyl substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R1 represents thienyl or furanyl optionally substituted by lower alkyl; or R1 represents hydrogen, if R0 represents a group of formula (Ia); R2 and R4 represent hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen or trifluoromethyl; n is 0, 1 or 2; COR3 carboxyl or carboxyl derivatized in form of a pharmaceutically acceptable ester; X represents a direct bond, C1-4-alkylene or C2-4-alkenylene; and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising said compounds; methods for preparation of said compounds and for the preparation of intermediates; and methods of treating disorders in mammals which are responsive to the inhibition of neutral endopeptidases by administration of said compounds to mammals in need of such treatment.
Patent DK-0621225-T3 (DK)
Inventor: HOEFLING PETER
IPC: B66B23/22
Filed: 1994-01-21
Granted: 1996-07-29
Abstract: A balustrade (1) of a passenger conveyor, such as an escalator or a moving pavement, is proposed which is provided with an encircling handrail (2) guided via rollers and which interacts outside the transport area (21) with a panel-like indicating and information device (7) which is releasably connected to the balustrade (1) and runs out with its one end (19) indirectly or directly into the area of the handrail turn (6). <IMAGE>
Patent DK-0719279-T3 (DK)
Inventor: KOTTENHAHN MATTHIAS
IPC: C07K1/14
Filed: 1994-08-19
Granted: 1998-07-27
Abstract: A process for purifying 1-[N2-((S)-ethoxycarbonyl)-3-phenylpropyl)-N6-trifluoroacetyl]-1-lysyl-1-proline by extraction and crystallization. The process includes a two step extraction in a two phase aqueous/organic solvent system and crystallization from organic solvent.
Patent DK-0690175-T3 (DK)
Inventor: HOFMANN FRANK
IPC: B05B9/06
Filed: 1995-06-10
Granted: 1999-03-01
Abstract: The spray pressure is varied dependent upon travelling and application speeds. With increasing spray pressure, and when a set max. pressure is exceeded, there is an increase in the size of the overall outlet cross-section. There is a drop to below a set min. pressure, there is a decrease of that cross-section for the marking material. The appliance has several spray nozzles (9a-c), and the size of the cross-section is varied by varying the number of open nozzles. The nozzles may have outlets of different sizes. Size variation may be automatic, after continuous measuring of a force on the spray system, which is dependent upon the spray pressure.
Patent DK-0689874-T3 (DK)
Inventor: REIDEL GUILLERMO DR
IPC: B05B11/02
Filed: 1995-06-12
Granted: 2002-01-14
Abstract: The device has two spray jets whose mouths are connected to a connector which combines the two fluids and ends in a spray head with spray nozzle (S). The dead volume is reduced by insert bodies. The spray head ends in a spray nozzle. The spray jets are filled with components of a multi-component adhesive. <IMAGE>
Patent DK-0732101-T3 (DK)
Inventor: MILGRAM NORTON W
IPC: A61P37/00
Filed: 1991-03-28
Granted: 1999-11-22
Abstract: L-deprenyl and pharmaceutically acceptable analog forms thereof are used at specific dosage levels and frequence of dosage to retard age dependent deterioration of the immune system function in mammals. The treatment can be especially useful for pets such as dogs and cats.
Patent DK-0732332-T3 (DK)
Inventor: HIRB NICHOLAS J
IPC: C07D295/00
Filed: 1996-03-11
Granted: 2002-04-15
Abstract: This invention relates to compounds of the formula I <CHEM>  wherein   X   is hydrogen, halogen, hydroxy, (C1-C6)alkoxy, amino or trifluoromethyl;  and   Y   is -CN or -NR<1>R<2>;  where   l   is an integer of 1 or 2; m   is an integer of 0, 1 or 2; n   is an integer of 2, 3 or 4, except when Y is CN, in which case n can also be 1; R<1>   is hydrogen, (C1-C6)alkyl or (C1-C6)alkylcarbonyl; R<2>   is hydrogen, (C1-C10)alkylcarbonyl, (C3-C12)cycloalkylcarbonyl, hydroxy-(C1-C6)alkylcarbonyl, phenylcarbonyl, thienylcarbonyl or  benzothienylcarbonyl; or   R<1> and R<2>   together with nitrogen atom to which they are attached form the ring <CHEM>    where   A   is C = O or CH2; and B   is C = O, CHOH, CH2 or CH2CH2; and Z   is hydrogen, halogen, hydroxy, (C1-C6)alkoxy, amino or trifluoro; and pharmaceutically acceptable acid addition salts thereof, pharmaceutical compositions thereof and their use for the treatment of psychoses.
Patent DK-0751070-T3 (DK)
Inventor: FERRERO PIETRO
IPC: B29C53/44
Filed: 1993-02-19
Granted: 2001-05-07
Abstract: Laminar bodies such as sheets of instructions or labels (F) are taken from a pack housed in a box (21) in order to be wound around a rotary head (8) which exerts a pneumatic gripping action on the laminar bodies (7) in order to roll them up to form cylindrical or tubular bodies. Each cylindrical or tubular body is then deposited in a housing cell (V). Alternatively, the same machine may also be used to produce container bodies formed by rolling up a laminar element. <IMAGE>
Patent DK-0747379-T3 (DK)
Inventor: LAVIELLE GILBERT
IPC: C07D403/14
Filed: 1996-06-06
Granted: 2000-01-31
Abstract: Indole, indazole and benzisoxazole derivs. of formula (I), their isomers and acid and base addn. salts are new. R, R1 = H, halo, 1-6C alkyl, 1-6C alkoxy, trihalomethyl or hydroxy; n = 1-6; Q = 3-benzoylmethyl-pyrrolidin-1-yl, 4-benzoyl-perhydroazepin-1-yl, 3-Ä3-methyl-pyrrolidin-1-ylÜ-1H-indazole, 3-Ä3-methyl-pyrrolidin-1-ylÜ-benzisoxazole or 3-Ä3-methyl-pyrrolidin-1-ylÜ-benzisothiazole (all benzene rings being substd. by R); X = NR2 and Y = CH or N; or X = O and Y =N; R2 = H or 1-6C alkyl (opt. substd. by one or more halo, alkyl, alkoxy, hydroxy or trihalomethyl). 10 Specific cpds. (I) are disclosed e.g. 3-ä2-Ä3-(4-fluorobenzoylmethyl)pyrrolidin-1-ylÜethylü-5-methoxy-indole hydrochloride; and 6-fluoro-3-ä1-Ä3-(5-methoxy-indol-3-yl)propylÜpyrrolidin-3-yl-methylü- 1,2-benzisoxazole hydrochloride.
Patent DK-0805796-T3 (DK)
Inventor: ADAMS STEVEN P
IPC: A61K31/426
Filed: 1996-01-18
Granted: 2003-03-31
Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.
Patent DK-0832654-T3 (DK)
Inventor: HIGASHI KAZUO
IPC: A61K51/04
Filed: 1997-09-18
Granted: 2003-03-31
Abstract: The present invention provides a radiation-protecting agent which protects the active ingredient of radiopharmaceuticals against the radiolysis caused by a reaction of the active ingredient with water radicals formed by radiolysis of water, without decomposing the reactive active ingredient such as readily reducible active ingredient. The radiation-protecting agent of the present invention is characterized by comprising an organic compound usable in medical drugs and having high physiological acceptability and protecting the radiolabeled active ingredient of radiopharmaceuticals against the action of radiation. The reaction rate constant of said organic compound with OH radical, H radical or hydrated electron must be in the range of from 1x10<8> to 5x10<10> M<-1>s<-1>, and when added to radiopharmaceuticals, molar concentration of the organic compound must be at least 50 times as high as molar concentration of the active ingredient.
Patent DK-0894836-T3 (DK)
Inventor: WEITZEL HANS-JOACHIM
IPC: C09D17/00
Filed: 1998-07-02
Granted: 2003-06-23
Abstract: A slurry consisting of (A) 25-70 wt% agglomerated, carbonate-containing pigment with a particle size distribution in which 80-99 wt% are below 2 microns in size, 50-90 wt% are below 1 micron and 0-10 wt% are below 0.2 micron, a steepness factor (SF = ratio of diameter at 50 wt% to diameter at 20 wt%) of 1.5-2.0 and a porosity of 45-65%, (B) 0.1-1.0 wt% known or commercially available dispersant which prevents the agglomerated pigment breaking up again in the slurry and (C) water (to 100 wt%). Also claimed is a process for production of the slurry.
Patent DK-0953162-T3 (DK)
Inventor: HECHT MARTIN
IPC: G02B6/50
Filed: 1998-01-20
Granted: 2001-08-13
Abstract: An optical wave-guide cable network can be extended into buildings easily, quickly and economically, in a flexible and operatively reliable manner, at any time of year. The optical wave-guide cable network includes the optical wave-guide cables mounted on the wall of inaccessible conduit or pipe systems by means of fixing elements. The fixing elements includes means for holding at least one optical wave-guide cable and means for fixing on the wall of the conduit or pipe system. The fixing means are formed by a resiliently prestressed, closed stainless steel ring which presses against the wall of the conduit or pipe system.
Patent DK-0991344-T3 (DK)
Inventor: VOELKER HEINRICH
IPC: A47C21/08
Filed: 1998-05-12
Granted: 2002-02-11
Abstract: A bed comprises a lower frame (12) having at least one leg or support element (16) for support on a ground and an upper frame (14) connected with the lower frame (12) and having a head element (22) and a foot element (24), as well as at least one connecting element (26) connecting the same. Further, a lying surface (46) having two longitudinal edges (48) extending between the head element (22) and the foot element (24), and at least one safety side element (52; 54) are provided, the at least one safety side element (52; 54) being slidable, beneath the lying surface (46), in a pull-out plane between an insert position and a maximum pull-out position. The at least one safety side element (52; 54) remains extending in the pull-out plane in any intermediate position between insert position and the maximum pull-out position. In its maximum pull-out position, it can be pivoted about a pivot axis (76) substantially parallel to the longitudinal edges (48) of the lying surface (46) into an upright position, a locking device (78) locking it against unintentional movement.
Patent DK-0979284-T3 (DK)
Inventor: MCMICHAEL ANDREW JAMES
IPC: C12N15/86
Filed: 1998-06-09
Granted: 2003-04-22
Abstract: New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumour antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition.
Patent DK-1004616-T3 (DK)
Inventor: KNEBELKAMP ARNO DR
IPC: C08J3/22
Filed: 1999-11-13
Granted: 2004-04-26
Abstract: Pigment master batch comprises: (A) 10-60 wt.% pigment; and (B) 40-90 wt.% micronized polyolefin and/or polyolefin wax, containing ≥ 1 wt.% material having a particle size 10 micro m, ≥ 10 wt.% material having a particle size 100 micro m, and ≥ 90 wt.% material having a particle size 500 micro m.
Patent DK-0961042-T3 (DK)
Inventor: MAURI GAETANO
IPC: F16B23/00
Filed: 1999-04-12
Granted: 2004-03-22
Abstract: Head for devices such as screws and the like which can be rotated by means of associated operating tools, comprising at least a first coaxial internal seat (20) which is substantially cylindrical and provided with radial flarings (21) extending radially from the side surface of the seat itself, said flarings having a conical end surface (21b) and lateral flanks (21a) which are parallel to one another and to the longitudinal axis of the screw itself for engagement with said operating tool. <IMAGE>
Patent DK-0933363-T3 (DK)
Inventor: BANKS BERNARD JOSEPH
IPC: A61K31/00
Filed: 1999-01-19
Granted: 2003-09-29
Abstract: Compounds of formula (I): <CHEM> or pharmaceutically, veterinarily or agriculturally acceptable salts thereof, or pharmaceutically, veterinarily or agriculturally acceptable solvates of either entity, wherein R<1> is 2,4,6-trisubstituted phenyl or 3,5-disubstituted pyridin-2-yl; R<3> is hydrogen; C2 to C5 alkyl substituted with one or more halo and with hydroxy; C2 to C5 alkanoyl substituted with one or more halo; C2 to C6 alkenyl optionally substituted with one or more halo; halo; amino or CONH2; R<5> is hydrogen, amino or halo; R<2> and R<4> are each independently selected from hydrogen, fluoro, chloro and bromo; R<6> and R<8> are hydrogen; and R<7> is hydrogen or C1 to C4 alkyl optionally substituted with one or more halo; are parasiticidal agents.
Patent DK-0974580-T3 (DK)
Inventor: OHUCHIDA SHUICHI
IPC: C07C405/00
Filed: 1999-07-20
Granted: 2002-09-30
Abstract: omega -Cycloalkyl-prostaglandin E1 derivatives of formula (I) <CHEM> wherein R<1> is OH etc.; X is Cl, F; R<2> is H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl which may be substituted; n is 0-4.), non-toxic salts thereof or cyclodextrin clathrates thereof can strongly bind on EP2 subtype receptor. Therefore, they are useful for the prevention and/or treatment of immunological diseases (autoimmune diseases, post-transplantation graft rejection etc.), asthma, abnormal bone formation, neuronal cell death, hepatopathy, abortion, premature birth or retina neuropathy (e.g. glaucoma) etc.
Patent DK-1090841-T3 (DK)
Inventor: POTTIER BENOIT
IPC: F16C13/02
Filed: 1999-10-07
Granted: 2004-06-14
Abstract: A quick release mechanism for a roller (6) wherein the roller (6) is mounted in a frame and rotationally driven (for example, a roller (6) carrying a roll of stretch wrapping film in a stretch wrapping head). The quick release mechanism includes a pair of stub axles (21,43) which support either end of the roller (6) in the frame. One of the stub axles (21) is fixed within the frame and driven by a motor. The connection between this driven stub axle (21) and the roller (6) ensures that no relative rotational movement occurs. The other stub axle (43) is "lockable" in a hole in the frame but is removable therefrom. The connection between the removable stub axle (43) and the roller (6) allows free relative rotational movement. Withdrawal of the removable stub axle (43) from the frame allows the roller (6) to be disconnected from its connection with the driven stub axle (21) and removed from the frame. Refitting of the roller (6) is simply a reversal of this process. <IMAGE>   <IMAGE>